Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management

Cellular Oncology

Volumn 32, Issue 4, 2010, Pages 275-283

  Hermsen, Mario A ^a   Sevilla, María A ^a   Llorente, José Luis ^a   Weiss, Marjan M ^b   Grimbergen, Anneliese ^b   Allonca, Eva ^a   Garcia Inclán, Cristina ^a   Balbín, Milagros ^a   Suárez, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genetic screening; Large deletion; Mutation; Paraganglioma; SDH

Indexed keywords

SUCCINATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; FEMALE; GENDER; GENE DELETION; GENE IDENTIFICATION; GENETIC SCREENING; GERM LINE; HEAD PARAGANGLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK PARAGANGLIOMA; NUCLEOTIDE SEQUENCE; PARAGANGLIOMA; PREDICTOR VARIABLE; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA; PEDIGREE; PREDICTIVE VALUE OF TESTS; SEX FACTORS; SPAIN; SUCCINATE DEHYDROGENASE;

EID: 77953449767     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0498     Document Type: Article

References (34)

1. D. Astuti, N. Hart-Holden, F. Latif et al., Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility, Clin. Endocrinol. 59 (2003), 728-733.
2. R.F. Badenhop, J.C. Jansen, P.A. Fagan et al., The prevalence of SDHB, SDHC and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features, J. Med. Genet. 41 (2004), e99.
3. J.P. Bayley, P. Devilee and P.E. Taschner, The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paragan-glioma and mitochondrial complex II deficiency, BMC Med. Genet. 6 (2005), 39.
4. J.P. Bayley, I. van Minderhout, M.M. Weiss et al., Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma, BMC Med. Genet. 7 (2006), 1.
5. B.E. Baysal, Clinical and molecular progress in hereditary paraganglioma, J. Med. Genet. 45 (2008), 689-694.
6. B.E. Baysal, J.E. Willett-Brozick, P.A. Filho, E.C. Lawrence, E.N. Myersand and R.E. Ferrell, An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma, J. Med. Genet. 41 (2004), 703-709.
7. B.E. Baysal, J.E. Willett-Brozick, E.C. Lawrence et al., Prevalence of SDHB, SDHC and SDHD germline mutations in clinic patients with head and neck paragangliomas, J. Med. Genet. 39 (2002), 178-183.
8. A. Cascon, S. Ruiz-Llorente, M.F. Fraga et al., Genetic and epi-genetic profile of sporadic pheochromocytomas, J. Med. Genet. 41 (2004), e30.
9. S. Chetan, C.S. Gujrathi and P.J. Donald, Current trends in the diagnosis and management of head and neck paragangliomas, Curr. Opin. Otolaryngol. Head Neck Surg. 13 (2005), 339-342.
10. H. Dannenberg, P. Komminoth, W.N. Dinjens, E.J. Speel and R.R. de Krijger, Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas, Endocr. Pathol. 14 (2003), 329-350.
11. N. Fakhry, P. Niccoli-Sire, A. Barlier-Seti, R. Giorgi, A. Giovanni and M. Zanaret, Cervical paragangliomas: is SDH genetic analysis systematically required?, Eur. Arch. Otorhino-laryngol. 265 (2008), 557-563.
12. O. Gimm, M. Armanios, H. Dziema, H.P. Neumann and C. Eng, Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromo-cytoma, Cancer Res. 60 (2000), 6822-6825.
13. R. Grantham, Amino acid difference formula to help explain protein evolution, Science 185 (1974), 862-864.
14. E.F. Hensen, E.S. Jordanova, I.J. van Minderhout et al., Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families, Oncogene 23 (2004), 4076-4083.
15. C.G. Jackson, Glomus tympanicum and glomus jugulare tumors, Otolaryngol. Clin. North Am. 34 (2001), 941-970.
16. J.H. Lee, F. Barich, L.H. Karnell et al., National Cancer Data Base report on malignant paragangliomas of the head and neck, Cancer 94 (2002), 730-737.
17. S. Manolidis, J.A. Shohet, C.G. Jackson and M.E. Glasscock, Malignant glomus tumors, Laryngoscope 109 (1999), 30-34.
18. T.P. Martin, R.M. Irving and E.R. Maher, The genetics of para-gangliomas: a review, Clin. Otolaryngol. 32 (2007), 7-11.
19. W.M. Mendenhall, R.W. Hinerman, R.J. Amdur et al., Treatment of paragangliomas with radiation therapy, Otolaryngol. Clin. North Am. 34 (2001), 1007-1020.
20. A.N. Mhatre, Y. Li, L. Feng, A. Gasperin and A.K. Lalwani, SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas, Clin. Genet. 66 (2004), 461-466.
21. J.L. Netterville, C.G. Jackson, F.R. Miller, J.R. Wanamaker and M.E. Glasscock, Vagal paraganglioma: a review of 46 patients treated during a 20-year period, Arch. Otolaryngol. Head Neck Surg. 124 (1998), 1133-1140.
22. H.P. Neumann, Z. Erlic, C.C. Boedeker et al., Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out, Cancer Res. 69 (2009), 3650-3656.
23. H.P. Neumann, C. Pawlu, M. Peczkowska et al., Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations, JAMA 292 (2004), 943-951.
24. P.K. Pellitteri, A. Rinaldo, D. Myssiorek et al., Paragangliomas of the head and neck, Oral Oncol. 40 (2004), 563-575.
25. A. Persu, M. Hamoir, V. Grégoire et al., High prevalence of SDHB mutations in head and neck paraganglioma in Belgium, J. Hypertens. 26 (2008), 1395-1401.
26. A. Rinaldo, D. Myssiorek, K.O. Devaney and A. Ferlito, Which paragangliomas of the head and neck have a higher rate of malignancy?, Oral Oncol. 40 (2004), 458-460.
27. M. Sanna, Y. Jain, G. De Donato, Rohit, L. Lauda and A. Taibah, Management of jugular paragangliomas: the Gruppo Otologico experience, Otol. Neurotol. 25 (2004), 797-804.
28. F. Schiavi, C.C. Boedeker, B. Bausch et al., Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene, JAMA 294 (2005), 2057-2063.
29. F. Schiavi, T. Savvoukidis, F. Trabalzini et al., Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas, Ann. N. Y. Acad. Sci. 1073 (2006), 190-197.
30. C. Suárez, J.P. Rodrigo, A. Ferlito et al., Tumors of familial origin in the head and neck, Oral Oncol. 42 (2006), 965-978.
31. C. Suárez, M.A. Sevilla and J.L. Llorente, Temporal paragan-gliomas, Eur. Arch. Otorhinolaryngol. 264 (2007), 719-731.
32. A.G.L. van der Mey, J.C. Jansen and J.M. van Baalen, Management of carotid body tumors, Otolaryngol. Clin. North Am. 34 (2001), 907-924.
33. F.H. van Nederveen, E. Korpershoek, J.W. Lenders, R.R. de Krijger and W.N. Dinjens, Somatic SDHB mutation in an ex-traadrenal pheochromocytoma, N. Engl. J. Med. 357(3) (2007), 306-308.
34. P.G. Wasserman and P. Savargaonkar, Paragangliomas: Classification, pathology, and differential diagnosis, Otolaryngol. Clin. North Am. 34 (2001), 845-862.